Table 2.
Management of moderate reactions
| Age | Patient type | No. of reactions | Predisposing factors | Subsequent management |
|---|---|---|---|---|
| <18 | EST | 1 | Not known | Reviewed in hospital and brought in for next infusion |
| <18 | EST | 1 | Nil | Brought in for next infusion |
| >18 | OP | 1 | Nil | Change of product for next infusion in hospital |
| >18 | EST | 2 | 1.Concomitant infection | Advice given |
| 2.Not known | Brought in for next infusion | |||
| >18 | EST | 1 | Concomitant infection | Continued as before |
| >18 | EST | 1 | Not known | Brought in for next infusion |
| >18 | EST | 1 | Not known | Continued as before |
| >18 | EST | 4 | Not known × 4 | Withdrawn from treatment after 4th reaction |
| >18 | GP | 2 | 1. Anti-IgA antibodies | 1.Reviewed in hospital; brought in for next infusion |
| 2. Anti-IgA antibodies, titre 1/2048 | 2.Reviewed in hospital; brought in for next infusion; change of product | |||
| >18 | EST | 1 | Concomitant infection; delay since last infusion; drop rate too fast | Advice given |
| >18 | EST | 1 | Concomitant infection; delay since last infusion | Brought in for next infusion |
| >18 | OP | 1 | Concomitant infection; delay since last infusion | Continued as before |
| >18 | EST | 1 | Concomitant infection | Continued as before |
| >18 | EST | 1 | Not known | Brought in for next infusion |
| >18 | OP | 1 | Concomitant infection; delay since last infusion | Continued as before |
n = 20. EST: established home infusions; OP: out-patient; GP: general practitioner.